Rethinking EDC: Why AI Demands a New Foundation for Clinical Data Management
At Veeva R&D and Quality Summit 2025, we spoke with Manny Vazquez, Senior Director of Clinical Data Strategy at...
NIH Funds Trial for Non-Surgical Knee Osteoarthritis Relief
Steadman Philippon Research Institute and Neuromuscular Dynamics have initiated a randomized, at-home trial in knee osteoarthritis testing an eight-week...
Kyowa Kirin Presents New Mogamulizumab Research at ASH 2025
No efficacy or safety rates were disclosed ahead of ASH, but the headline is a Phase 2, single-arm evaluation...
Radiopharm Begins Promising Phase 1 Prostate Cancer Trial
Radiopharm Theranostics has received ethics approval from Australia’s Bellberry HREC to initiate a first-in-human Phase 1 study of RAD...
Annovis Announces FDA Meeting for Parkinson’s, Alzheimer’s
No new efficacy or safety data accompanied Annovis Bio’s update. The company reported two regulatory developments: FDA has scheduled...
HCW Biologics Begins First-in-Human Trial for Autoimmunity
HCW Biologics has dosed the first patient in its multi-center, first-in-human Phase 1 trial of HCW9302 (NCT07049328) in alopecia...
Navepegritide Trial Results for Children with Achondroplasia
TransCon CNP (navepegritide) met the primary endpoint in the 52-week, randomized, double-blind ApproaCH trial, delivering a statistically significant increase...
T-Knife Files for Phase 1 Trial of PRAME T-Cell Therapy
No clinical data were disclosed. The update centers on a regulatory filing to begin first-in-human testing and preclinical evidence...
Protara to Present New TARA-002 Data for NMIBC Patients
Protara Therapeutics will present interim safety and efficacy data from 31 BCG‑naïve patients in Cohort A of the Phase...
Promising RAD101 Brain Imaging Trial Reaches 50% Mark
Early Phase 2b imaging readouts from the first three patients showed selective 18F-RAD101 uptake in brain metastases where MRI...
